News

Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a major phase III clinical trial.

Researchers have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) and a diagnostic test to determine which AML patients would most likely benefit from this treatment.

The newly discovered adhesion complex can provide answers to an as-yet unanswered question – how the cell can remain attached to the matrix during cell division.

Treating the prostate with radiotherapy alongside standard treatment led to a 11 percent increase in survival for some men with advanced prostate cancer, shows trial.

In new studies a novel oxygen-delivery therapeutic restored the function of oxygen-starved heart tissue in an animal model of global hypoxia. Unlike its experimental predecessors, the new drug does not appear to cause systemic side effects or overcorrect with excessive blood oxygenation, which can itself be toxic. Instead, the new drug delivers its precious oxygen cargo only to the tissues that need it most.

New research has shown that by using a combination of immunotherapy and chemotherapy the body’s own immune system can be tuned to attack triple-negative breast cancer, extending survival by up to ten months.

UNIGE and HUG scientists show that rare ovarian and pancreatic cancers in young women are caused by cells that have settled in an organ other than the one for which they were intended during embryogenesis.

This 3D neuro-model could help uncover early stage biomarkers of disease, in turn supporting earlier diagnosis and improving understanding of disease progression.

Fat is powering tumour growth in brain cancer, finds a new study by Cardiff University and the University of Florida.

A novel method of overcoming treatment resistance to both PD-1 and adoptive cellular therapy has been identified, by employing a concomitant hematopoietic stem and progenitor cell transfer.